4
Changes in Ownership
PharmaCyte Biotech, Inc. Filed Acc 0001683168-25-009114
CEO and President gave up 258,750 shares (to pay taxes)
- CEO and President acquired 575,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Silverman Joshua · CEO and President
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-12 | Grant or award : show line 1 in the form | +575,000 | 575,000 | D | ||
| 2025-12-12 | Shares withheld for taxes : show line 2 in the form | −258,750 | $1.02 | $263,925 | 316,250 | D |
Loading xslF345X05/ownership.xml…